A carregar...
Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies
This review focuses on the use of recombinant porcine factor VIII (FVIII) for the treatment of bleeding episodes in patients with severe haemophilia A complicated by inhibitors and in those with acquired haemophilia A due to the onset of anti-FVIII autoantibodies. We present the main characteristics...
Na minha lista:
| Publicado no: | Blood Transfus |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Edizioni SIMTI - SIMTI Servizi Srl
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490733/ https://ncbi.nlm.nih.gov/pubmed/27483484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2016.0030-16 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|